BLPH

Bellerophon Therapeutics, Inc.
BLPH

Overview Fund Activity
Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

26 hedge funds and large institutions have $29.1M invested in Bellerophon Therapeutics, Inc. in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
5
Increased
6
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
1
Armistice Capital
New York
$1.89M
2
SM
2
Sabby Management
Florida
$202K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$649K
4
TI
4
Telemetry Investments
New York
$126K
5
VMI
5
VHCP Management III
New York
$1.58M

Top Sellers

1
ARTA
1
A.R.T. Advisors
New York
$0
2
BCM
2
Bridgeway Capital Management
Texas
$103K
3
VF
3
Virtu Financial
New York
$11K
4
LTFS
4
Ladenburg Thalmann Financial Services
Florida
$0
5
BlackRock
5
BlackRock
New York
$40K
Name Holding Trade Value Shares
Change 		Shares
Change %
ARTA
26
A.R.T. Advisors
New York
– -$24K -2,032 Closed
LTFS
27
Ladenburg Thalmann Financial Services
Florida
– -$3K -267 Closed
SWM
28
SeaCrest Wealth Management
New York
– -$2K -200 Closed
1
2